Status:
RECRUITING
Treatment of Multiple Gingival Recession Defects Using a New Xenogenic Collagen Membrane Compared to Connective Tissue Graft: a Randomized Controlled Split-mouth Clinical Study
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Gingival Recession
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Limitation of donor site and significant postoperative morbidity are often described in connective tissue graft. We want to show if mucogain matrix used in tunnel technique to recover RTI Cairo recess...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Patient with 3 contiguous, symmetrical and bilateral RTI Cairo gingival recessions (Miller Class 1) (i.e. 6 recessions)
- Patient non-smoker
- Patient affiliated to social security
- Patient signed informed consent.
- Exclusion criteria:
- Patient with or having presented an acute or chronic severe cardiovascular, kidney, liver, gastrointestinal, allergic, endocrine, neuropsychiatric pathology, developed cancer of the upper aero digestive tract treated with radiotherapy
- Patient with severe hemorrhinopathy
- Patient treated with oral retinoids, bisphosphonates, oral or anticonvulsants
- Patient who has taken steroidal or non-steroidal anti-inflammatory therapy, anti-cancer or immunosuppressive chemotherapy within the last 6 months.
- Patient with contraindication to necessary and pre-, per- or post-operative treatments
- Follow-up of the patient seemed difficult by the investigator
- Patient with insufficient oral hygiene incompatible with oral surgery
Exclusion
Key Trial Info
Start Date :
July 24 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04800250
Start Date
July 24 2023
End Date
January 1 2025
Last Update
February 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Nice
Nice, Provence-Alpes-Côte d'Azur Region, France, 06000